Increased plasma cell frequency and accumulation of abnormal syndecan-1plus T-cells in Igμ-deficient/lpr mice

International Immunology

Volumn 15, Issue 9, 2003, Pages 1045-1052

  Seagal, Jane ^a   Leider, Nira ^a   Wildbaum, Gizi ^a   Karin, Nathan ^a   Melamed, Doron ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

B cell development; Fas signaling; Lupus; Self tolerance; Serum antibody

Indexed keywords

CD3 ANTIGEN; CD45 ANTIGEN; FAS ANTIGEN; FAS LIGAND; IMMUNOGLOBULIN M; LYMPHOCYTE SURFACE MARKER; PROTEOGLYCAN; SYNDECAN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY TITER; B LYMPHOCYTE DIFFERENTIATION; CONTROLLED STUDY; GENE SWITCHING; IMMUNOGLOBULIN DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOPHENOTYPING; IMMUNOREGULATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOPENIA; LYMPHOCYTOPOIESIS; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD3; ANTIGENS, CD95; CELL DIFFERENTIATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNOGLOBULIN MU-CHAINS; IMMUNOPHENOTYPING; LUPUS ERYTHEMATOSUS, SYSTEMIC; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED MRL LPR; MICE, MUTANT STRAINS; MICE, TRANSGENIC; PLASMA CELLS; PROTEOGLYCANS; RECEPTORS, ANTIGEN, B-CELL; SPLEEN; SYNDECAN-1; SYNDECANS; T-LYMPHOCYTES; TH1 CELLS;

EID: 0042854701     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxg107     Document Type: Review

References (58)

1. Rajewsky, K. 1996. Clonal selection and learning in the antibody system. Nature 381:751.
2. Rolink, A. G., Schaniel, C., Andersson, J. and Melchers, F. 2001. Selection events operating at various stages in B cell development. Curr. Opin. Immunol. 13:202.
3. Niiro, H. and Clark, E. A. 2002. Regulation of B-cell fate by antigen-receptor signals. Nat. Rev. Immunol. 2:945.
4. Seagal, J. and Melamed, D. 2002. Role of receptor revision in forming a B cell repertoire. Clin. Immunol. 105:1.
5. Nemazee, D. 2000. Receptor selection in B and T lymphocytes. Annu. Rev. Immunol. 18:19.
6. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355.
7. Van Parijs, L., Peterson, D. A. and Abbas, A. K. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity 8:265.
8. Foote, L. C., Marshak-Rothstein, A. and Rothstein, T. L. 1998. Tolerant B lymphocytes acquire resistance to Fas-mediated apoptosis after treatment with interleukin 4 but not after treatment with specific antigen unless a surface immunoglobulin threshold is exceeded. J. Exp. Med. 187:847.
9. Rathmell, J. C. and Goodnow, C. C. 1998. The in vivo balance between B cell clonal expansion and elimination is regulated by CD95 both on B cells and in their micro-environment. Immunol. Cell Biol. 76:387.
10. Rubio, C. F., Kench, J., Russell, D. M., Yawger, R. and Nemazee, D. 1996. Analysis of central B cell tolerance in autoimmune-prone MRL/lpr mice bearing autoantibody transgenes. J. Immunol. 157:65.
11. Kench, J. A., Russell, D. M. and Nemazee, D. 1998. Efficient peripheral clonal elimination of B lymphocytes in MRL/lpr mice bearing autoantibody transgenes. J. Exp. Med. 188:909.
12. Rathmell, J. C. and Goodnow, C. C. 1994. Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. J. Immunol. 153:2831.
13. Cohen, P. L. and Eisenberg, R. A. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243.
14. Katagiri, T., Azuma, S., Toyoda, Y., Mori, S., Kano, K., Cohen, P. L. and Eisenberg, R. A. 1992. Tetraparental mice reveal complex cellular interactions of the mutant, autoimmunity-inducing lpr gene. J. Immunol. 148:430.
15. + T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice. J. Exp. Med. 167:1713.
16. Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M. and Huszar, D. 1994. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180:1295.
17. Kitamura, D., Roes, J., Kuhn, R. and Rajewsky, K. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350:423.
18. Melamed, D., Miri, E., Leider, N. and Nemazee, D. 2000. Unexpected autoantibody production in membrane Ig-μ-deficient/lpr mice. J. Immunol. 165:4353.
19. Spira, G., Gregor, P. D, and Scharff, M. D. 1993. The use of chemiluminescence and the ELISA spot assay to identify and enumerate rare immunoglobulin switch variants. J. Immunol. Methods 165:263.
20. r1 cell-dependent active tolerance blunts the pathogenic effects of determinant spreading. J. Clin. Invest. 110:701.
21. Theofilopoulos, A. N., Shawler, D. L., Eisenberg, R. A. and Dixon, F. J. 1980. Splenic immunoglobulin-secreting cells and their regulation in autoimmune mice. J. Exp. Med. 151:446.
22. h1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J. Clin. Invest. 97:1597.
23. Balomenos, D., Rumold, R. and Theofilopoulos, A. N. 1998. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J. Clin. Invest. 101:364.
24. Macpherson, A. J., Lamarre, A., McCoy, K., Harriman, G. R., Odermatt, B., Dougan, G., Hengartner, H. and Zinkernagel, R. M. 2001. IgA production without mu or delta chain expression in developing B cells. Nat. Immunol, 2:625.
25. Kadowaki, N., Amakawa, R., Hayashi, T., Akasaka, T., Yabumoto, K., Ohno, H., Fukuhara, S. and Okuma, M. 1995. Immunoglobulin heavy chain class switching, mu to gamma, in a human lymphoma cell line FL-318 carrying a t(14;18)(q32;q21) chromosomal translocation. Leukemia 9:1139.
26. Rolink, A., Melchers, F. and Andersson, J. 1996. The SCID but not the RAG-2 gene product is required for Sμ-Sε heavy chain class switching. Immunity 5:319.
27. Brard, F., Shannon, M., Prak, E. L., Litwin, S. and Weigert, M. 1999. Somatic mutation and light chain rearrangement generate autoimmunity in anti-single-stranded DNA transgenic MRL/lpr mice. J. Exp. Med. 190:691.
28. Klonowski, K. D. and Monestier, M. 2000. Heavy chain revision in MRL mice: a potential mechanism for the development of autoreactive B cell precursors. J. Immunol. 165:4487.
29. Toyama, H., Okada, S., Hatano, M., Takahashi, Y., Takeda, N., Ichii, H., Takemori, T., Kuroda, Y. and Tokuhisa, T. 2002. Memory B cells without somatic hypermutation are generated from Bcl6-deficient B cells. Immunity 17:329.
30. William, J., Euler, C., Christensen, S. and Shlomchik, M. J. 2002. Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science 297:2066.
31. + T cells. Nature 376:181.
32. Krammer, P. H. 2000. CD95's deadly mission in the immune system. Nature 407:789.
33. Wang, H. and Shlomchik, M. J. 1999. Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice. J. Exp. Med. 190:639.
34. Mandik-Nayak, L., Seo, S. J., Sokol, C., Potts, K. M., Bui, A. and Erikson, J. 1999. MRL-lpr/lpr mice exhibit a defect in maintaining developmental arrest and follicular exclusion of anti-double-stranded DNA B cells. J. Exp. Med. 189:1799.
35. Peng, S. L., Madaio, M. P., Hayday, A. C. and Craft, J, 1996. Propagation and regulation of systemic autoimmunity by γδ T cells. J. Immunol. 157:5689.
36. Seery, J. P., Wang, E. C., Cattell, V., Carroll, J. M., Owen, M. J. and Watt, F. M. 1999. A central role for αβ T cells in the pathogenesis of murine lupus. J. Immunol. 162:7241.
37. Chesnutt, M. S., Finck, B. K., Killeen, N., Connolly, M, K., Goodman, H. and Wofsy, D. 1998. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice. Clin. Immunol. Immunopathol. 87:23.
38. Wen, L., Pao, W., Wong, F. S., Peng, Q., Craft, J., Zheng, B., Kelsoe, G., Dianda, L., Owen, M. J. and Hayday, A. C. 1996. Germinal center formation, immunoglobulin class switching, and autoantibody production driven by 'non alpha/beta' T cells. J. Exp. Med. 183:2271.
39. Boes, M., Schmidt, T., Linkemann, K., Beaudette, B. C., Marshak-Rothstein, A. and Chen, J. 2000. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl Acad. Sci. USA 97:1184.
40. Chan, O. and Shlomchik, M. J. 1998. A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice. J. Immunol. 160:51.
41. + thymic precursor. J. Immunol. 151:1086.
42. - T-cells increase in MRI/lpr mice treated with thymic factors. Int. J. Immunopharmacol. 16:651.
43. Russell, J. H., Rush, B., Weaver, C. and Wang, R. 1993. Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc. Natl Acad. Sci. USA 90:4409.
44. Watanabe, D., Suda, T., Hashimoto, H. and Nagata, S. 1995. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14:12.
45. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
46. Renno, T., Hahne, M., Tschopp, J. and MacDonald, H. R. 1996. Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J. Exp. Med. 183:431.
47. Fukuyama, H., Adachi, M., Suematsu, S., Miwa, K., Suda, T., Yoshida, N. and Nagata, S. 1998. Transgenic expression of Fas in T cells blocks lymphoproliferation but not autoimmune disease in MRL/lpr mice. J. Immunol. 160:3805.
48. Hughes, D. P., Hayday, A., Craft, J. E., Owen, M. J. and Crispe, I. N. 1995. T cells with gamma/delta T cell receptors (TCR) of intestinal type are preferentially expanded in TCR-alpha-deficient lpr mice. J. Exp. Med. 182:233.
49. Sanderson, R. D. and Borset, M. 2002. Syndecan-1 in B lymphoid malignancies. Ann. Hematol. 81:125.
50. Kopper, L. and Sebestyen, A. 2000. Syndecans and the lymphoid system. Leuk. Lymphoma 38:271.
51. Couchman, J. R., Chen, L. and Woods, A. 2001. Syndecans and cell adhesion. Int. Rev. Cytol. 207:113.
52. Gotte, M. 2003. Syndecans in inflammation. FASEB J. 17:575.
53. Bobardt, M. D., Saphire, A. C., Hung, H. C., Yu, X., Van der Schueren, B., Zhang, Z., David, G. and Gallay, P. A. 2003. Syndecan captures, protects, and transmits HIV to T lymphocytes. Immunity 18:27.
54. Davignon, J. L., Budd, R. C., Ceredig, R., Piguet, P. F., MacDonald, H. R., Cerottini, J. C., Vassalli, P. and Izui, S. 1985. Functional analysis of T cell subsets from mice bearing the lpr gene. J. Immunol. 135:2423.
55. Sobel, E. S., Kakkanaiah, V. N., Rapoport, R. G., Eisenberg, R. A. and Cohen, P. L. 1995. The abnormal lpr double-negative T cell fails to proliferate in vivo. Clin. Immunol. Immunopathol. 74:177.
56. Dailey, M. O. and Jensen, R. 1994. Autoimmune lpr and gld mice: models of abnormal adhesion molecule regulation and defective lymphocyte traffic. Adv. Exp. Med. Biol. 355:119.
57. Jevnikar, A. M., Grusby, M. J. and Glimcher, L. H. 1994. Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J. Exp. Med. 179:1137.
58. Maldonado, M. A., Eisenberg, R. A., Roper, E., Cohen, P. L. and Kotzin, B. L. 1995. Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. J. Exp. Med. 181:641.